Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0V5FQ
|
||||
Former ID |
DIB005116
|
||||
Drug Name |
Axitirome
|
||||
Synonyms |
CGP-26214; CGS-25845; CGS-26214
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Hyperlipidaemia [ICD9: 272.0-272.4; ICD10:E78] | Phase 1 | [544305] | ||
Company |
Novartis AG
|
||||
Structure |
Download2D MOL |
||||
Formula |
C25H24FNO6
|
||||
Canonical SMILES |
c1(C(c2ccc(cc2)F)O)c(ccc(Oc2c(cc(NC(=O)C(=O)OCC)cc2C)C)<br />c1)O
|
||||
CAS Number |
CAS 156740-57-7
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Thyroid hormone receptor beta-1 | Target Info | Modulator | [544305] | |
Pathway Interaction Database | RXR and RAR heterodimerization with other nuclear receptor | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.